The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer

Steroids

Volumn 77, Issue 11, 2012, Pages 1107-1112

  Krishnan, Aruna V ^a   Swami, Srilatha ^a   Feldman, David ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aromatase; Breast cancer; Calcitriol; Dietary vitamin D; Estrogen receptor; Prostaglandins

Indexed keywords

AROMATASE; CALCIDIOL 1 MONOOXYGENASE; CALCITRIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA;

ADIPOSE TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER CELL; CANCER INVASION; CANCER PREVENTION; CELL CYCLE ARREST; DRUG EFFICACY; ENZYME REGULATION; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; ESTROGEN SYNTHESIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; MICROENVIRONMENT; MITOSIS INHIBITION; PROMOTER REGION; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANTINEOPLASTIC AGENTS; AROMATASE INHIBITORS; BREAST NEOPLASMS; CALCITRIOL; CELL LINE, TUMOR; CELL SURVIVAL; DIETARY SUPPLEMENTS; ESTROGENS; FEMALE; HUMANS; NEOPLASMS, HORMONE-DEPENDENT; RECEPTORS, ESTROGEN; VITAMIN D; VITAMINS;

MUS;

EID: 84865483908     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2012.06.005     Document Type: Review

References (79)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2 2011 69 90
2. R. Riemsma, C.A. Forbes, A. Kessels, K. Lykopoulos, M.M. Amonkar, and D.W. Rea Systematic review of aromatase inhibitors in the first-line treatment for hormone sensitive advanced or metastatic breast cancer Breast Cancer Res Treat 123 1 2010 9 24
3. J. Geisler, and P.E. Lonning Aromatase inhibition: translation into a successful therapeutic approach Clin Cancer Res 11 8 2005 2809 2821
4. P. Goss, and M. Wu Application of aromatase inhibitors in endocrine responsive breast cancers Breast 16 Suppl 2007 2S114-2S119
5. D. Feldman, P.J. Malloy, A.V. Krishnan, and E. Balint Vitamin D: biology action and clinical implications R. Marcus, D. Feldman, D.A. Nelson, C.J. Rosen, Osteoporosis, 3rd ed vol. 1 2007 Elsevier San Diego
6. T.M. Beer, and A. Myrthue Calcitriol in cancer treatment: from the lab to the clinic Mol Cancer Ther 3 3 2004 373 381
7. K.W. Colston, and C.M. Hansen Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer Endocr Relat Cancer 9 1 2002 45 59
8. K.K. Deeb, D.L. Trump, and C.S. Johnson Vitamin D signalling pathways in cancer: potential for anticancer therapeutics Nat Rev Cancer 7 9 2007 684 700
9. D.M. Harris, and V.L. Go Vitamin D and colon carcinogenesis J Nutr 134 12 Suppl 2004 3463S 3471S
10. A.V. Krishnan, and D. Feldman Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D Annu Rev Pharmacol Toxicol 51 2011 311 336
11. A.V. Krishnan, D.L. Trump, C.S. Johnson, and D. Feldman The role of vitamin D in cancer prevention and treatment Endocrinol Metab Clin North Am 39 2 2010 401 418 table of contents
12. Q.T. Luong, and H.P. Koeffler Vitamin D compounds in leukemia J Steroid Biochem Mol Biol 97 1-2 2005 195 202
13. D. Matthews, E. LaPorta, G.M. Zinser, C.J. Narvaez, and J. Welsh Genomic vitamin D signaling in breast cancer: insights from animal models and human cells J Steroid Biochem Mol Biol 121 1-2 2010 362 367
14. K. Colston, and J. Welsh Vitamin D and breast cancer D. Feldman, J.W. Pike, F.H. Glorieux, Vitamin D, Second vol. 2 2005 Elsevier Academic Press San Diego 1663 1677
15. C.F. Garland, E.D. Gorham, S.B. Mohr, W.B. Grant, E.L. Giovannucci, and M. Lipkin Vitamin D and prevention of breast cancer: pooled analysis J Steroid Biochem Mol Biol 103 3-5 2007 708 711
16. E. Giovannucci The epidemiology of vitamin D and cancer incidence and mortality: a review (United States) Cancer Causes Control 16 2 2005 83 95
17. Y.M. Coyle The effect of environment on breast cancer risk Breast Cancer Res Treat 84 3 2004 273 288
18. Y. Cui, and T.E. Rohan Vitamin D, calcium, and breast cancer risk: a review Cancer Epidemiol Biomarkers Prev 15 8 2006 1427 1437
19. D.M. Freedman, M. Dosemeci, and K. McGlynn Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study Occup Environ Med 59 4 2002 257 262
20. J.A. Knight, M. Lesosky, H. Barnett, J.M. Raboud, and R. Vieth Vitamin D and reduced risk of breast cancer: a population-based case-control study Cancer Epidemiol Biomarkers Prev 16 3 2007 422 429
21. E. Giovannucci Vitamin D status and cancer incidence and mortality Adv Exp Med Biol 62 2008 31 42
22. K.J. Helzlsouer Overview of the cohort consortium vitamin D pooling project of rarer cancers Am J Epidemiol 172 1 2010 4 9
23. R.Z. Stolzenberg-Solomon, E.J. Jacobs, A.A. Arslan, D. Qi, A.V. Patel, and K.J. Helzlsouer Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: cohort consortium vitamin D pooling project of rarer cancers Am J Epidemiol 172 1 2010 81 93
24. W.B. Grant Critique of the U-shaped serum 25-hydroxyvitamin D level-disease response relation Dermatoendocrinol 1 6 2009 289 293
25. J. Welsh, J.A. Wietzke, G.M. Zinser, B. Byrne, K. Smith, and C.J. Narvaez Vitamin D-3 receptor as a target for breast cancer prevention J Nutr 133 7 Suppl 2003 2425S 2433S
26. J. Welsh, J.A. Wietzke, G.M. Zinser, S. Smyczek, S. Romu, and E. Tribble Impact of the vitamin D3 receptor on growth-regulatory pathways in mammary gland and breast cancer J Steroid Biochem Mol Biol 83 1-5 2002 85 92
27. C.J. Narvaez, G. Zinser, and J. Welsh Functions of 1alpha, 25-dihydroxyvitamin D(3) in mammary gland: from normal development to breast cancer Steroids 66 3-5 2001 301 308
28. F.S. Fan, and W.C. Yu 1,25-Dihydroxyvitamin D3 suppresses cell growth, DNA synthesis, and phosphorylation of retinoblastoma protein in a breast cancer cell line Cancer Invest 13 3 1995 280 286
29. S.S. Jensen, M.W. Madsen, J. Lukas, L. Binderup, and J. Bartek Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery Mol Endocrinol 15 8 2001 1370 1380
30. M. Simboli-Campbell, C.J. Narvaez, K. van Weelden, M. Tenniswood, and J. Welsh Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells Breast Cancer Res Treat 42 1 1997 31 41
31. G. Pirianov, and K.W. Colston Interactions of vitamin D analogue CB1093, TNFalpha and ceramide on breast cancer cell apoptosis Mol Cell Endocrinol 172 1-2 2001 69 78
32. D. Rocker, A. Ravid, U.A. Liberman, O. Garach-Jehoshua, and R. Koren 1,25-Dihydroxyvitamin D3 potentiates the cytotoxic effect of TNF on human breast cancer cells Mol Cell Endocrinol 106 1-2 1994 157 162
33. N. Pendas-Franco, J.M. Gonzalez-Sancho, Y. Suarez, O. Aguilera, A. Steinmeyer, and C. Gamallo Vitamin D regulates the phenotype of human breast cancer cells Differentiation 75 3 2007 193 207
34. Q. Wang, D. Lee, V. Sysounthone, R.A.S. Chandraratna, S. Christakos, and R. Korah 1,25-dihydroxyvitamin D3 and retonic acid analogues induce differentiation in breast cancer cells with function- and cell-specific additive effects Breast Cancer Res Treat 67 2 2001 157 168
35. L. Flanagan, K. Packman, B. Juba, S. O'Neill, M. Tenniswood, and J. Welsh Efficacy of vitamin D compounds to modulate estrogen receptor negative breast cancer growth and invasion J Steroid Biochem Mol Biol 84 2-3 2003 181 192
36. C.M. Hansen, T.L. Frandsen, N. Brunner, and L. Binderup 1Alpha,25-dihydroxyvitamin D3 inhibits the invasive potential of human breast cancer cells in vitro Clin Exp Metastasis 12 3 1994 195 202
37. K. Koli, and J. Keski-Oja 1Alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells Cell Growth Differ 11 4 2000 221 229
38. P. Allavena, C. Garlanda, M.G. Borrello, A. Sica, and A. Mantovani Pathways connecting inflammation and cancer Curr Opin Genet Dev 18 1 2008 3 10
39. A. Mantovani, and M.A. Pierotti Cancer and inflammation: a complex relationship Cancer Lett 267 2 2008 180 181
40. A.V. Krishnan, and D. Feldman Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment Endocr Relat Cancer 17 1 2010 R19 38
41. A.V. Krishnan, S. Swami, and D. Feldman Vitamin D and breast cancer: inhibition of estrogen synthesis and signaling J Steroid Biochem Mol Biol 121 1-2 2010 343 348
42. S.H. Chang, C.H. Liu, R. Conway, D.K. Han, K. Nithipatikom, and O.C. Trifan Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression Proc Natl Acad Sci USA 101 2 2004 591 596
43. D. Wang, and R.N. Dubois Cyclooxygenase-2: a potential target in breast cancer Semin Oncol 31 1 Suppl 3 2004 64 73
44. A. Ristimaki, A. Sivula, J. Lundin, M. Lundin, T. Salminen, and C. Haglund Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer Cancer Res 62 3 2002 632 635
45. I. Wolf, J. O'Kelly, T. Rubinek, M. Tong, A. Nguyen, and B.T. Lin 15-Hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer Cancer Res 66 15 2006 7818 7823
46. A.V. Krishnan, S. Swami, L. Peng, J. Wang, J. Moreno, and D. Feldman Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy Endocrinology 151 1 2010 32 42
47. A.M. Brodie, Q. Lu, B.J. Long, A. Fulton, T. Chen, and N. Macpherson Aromatase and COX-2 expression in human breast cancers J Steroid Biochem Mol Biol 79 1-5 2001 41 47
48. R.W. Brueggemeier, A.L. Quinn, M.L. Parrett, F.S. Joarder, R.E. Harris, and F.M. Robertson Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens Cancer Lett 140 1-2 1999 27 35
49. S. Swami, A.V. Krishnan, J.Y. Wang, K. Jensen, L. Peng, and M.A. Albertelli Inhibitory effects of calcitriol on the growth of MCF-7 breast cancer xenografts in nude mice. selective modulation of aromatase expression in vivo Horm Cancer 2 3 2011 190 202
50. A. Stoica, M. Saceda, A. Fakhro, H.B. Solomon, B.D. Fenster, and M.B. Martin Regulation of estrogen receptor-alpha gene expression by 1,25-dihydroxyvitamin D in MCF-7 cells J Cell Biochem 75 4 1999 640 651
51. S. Swami, A.V. Krishnan, and D. Feldman 1Alpha, 25-dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells Clin Cancer Res 6 8 2000 3371 3379
52. S. Chen Aromatase and breast cancer Front Biosci 3 1998 d922 d933
53. A. Brodie, B. Long, and Q. Lu Aromatase expression in the human breast Breast Cancer Res Treat 49 Suppl 1S85-91 1998 discussion S109-S119
54. E.R. Simpson, C. Clyne, G. Rubin, W.C. Boon, K. Robertson, and K. Britt Aromatase - a brief overview Annu Rev Physiol 64 2002 93 127
55. A. Enjuanes, N. Garcia-Giralt, A. Supervia, X. Nogues, L. Mellibovsky, and J. Carbonell Regulation of CYP19 gene expression in primary human osteoblasts: effects of vitamin D and other treatments Eur J Endocrinol 148 5 2003 519 526
56. T. Yanase, S. Suzuki, K. Goto, M. Nomura, T. Okabe, and R. Takayanagi Aromatase in bone: roles of vitamin D3 and androgens J Steroid Biochem Mol Biol 86 3-5 2003 393 397
57. S.V. Hughes, E. Robinson, R. Bland, H.M. Lewis, P.M. Stewart, and M. Hewison 1,25-Dihydroxyvitamin D3 regulates estrogen metabolism in cultured keratinocytes Endocrinology 138 9 1997 3711 3718
58. Y.R. Lou, T. Murtola, and P. Tuohimaa Regulation of aromatase and 5alpha-reductase by 25-hydroxyvitamin D(3), 1alpha,25-dihydroxyvitamin D(3), dexamethasone and progesterone in prostate cancer cells J Steroid Biochem Mol Biol 94 1-3 2005 151 157
59. D. Zhou, and S. Chen Identification and characterization of a cAMP-responsive element in the region upstream from promoter 1.3 of the human aromatase gene Arch Biochem Biophys 371 2 1999 179 190
60. E.S. Diaz-Cruz, C.L. Shapiro, and R.W. Brueggemeier Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells J Clin Endocrinol Metab 90 5 2005 2563 2570
61. Y. Zhao, V.R. Agarwal, C.R. Mendelson, and E.R. Simpson Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene Endocrinology 137 12 1996 5739 5742
62. R.W. Brueggemeier Update on the use of aromatase inhibitors in breast cancer Expert Opin Pharmacother 7 14 2006 1919 1930
63. J. Wheler, M. Johnson, and A. Seidman Adjuvant therapy with aromatase inhibitors for postmenopausal women with early breast cancer: evidence and ongoing controversy Semin Oncol 33 6 2006 672 680
64. C.B. Confavreux, A. Fontana, J.P. Guastalla, F. Munoz, J. Brun, and P.D. Delmas Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates Bone 41 3 2007 346 352
65. B.A. Mincey, M.S. Duh, S.K. Thomas, E. Moyneur, M. Marynchencko, and S.P. Boyce Risk of cancer treatment-associated bone loss and fractures among women with breast cancer receiving aromatase inhibitors Clin Breast Cancer 7 2 2006 127 132
66. C. Jordan Historical perspective on hormonal therapy of advanced breast cancer Clin Ther 24 Suppl 2002 AA3 AA16
67. S.Y. James, A.G. Mackay, L. Binderup, and K.W. Colston Effects of a new synthetic vitamin D analogue, EB1089, on the oestrogen-responsive growth of human breast cancer cells J Endocrinol 141 3 1994 555 563
68. J. Abe-Hashimoto, T. Kikuchi, T. Matsumoto, Y. Nishii, E. Ogata, and K. Ikeda Antitumor effect of 22-oxa-calcitriol, a noncalcemic analogue of calcitriol, in athymic mice implanted with human breast carcinoma and its synergism with tamoxifen Cancer Res 53 11 1993 2534 2537
69. T. Vink-van Wijngaarden, H.A. Pols, C.J. Buurman, G.J. van den Bemd, L.C. Dorssers, and J.C. Birkenhager Inhibition of breast cancer cell growth by combined treatment with vitamin D3 analogues and tamoxifen Cancer Res 54 21 1994 5711 5717
70. M. Hewison Vitamin D and innate and adaptive immunity Vitam Horm 25 2011 8623 8762
71. M. Hewison Antibacterial effects of vitamin D Nat Rev Endocrinol 7 6 2011 337 345
72. C.M. Kemmis, S.M. Salvador, K.M. Smith, and J. Welsh Human mammary epithelial cells express CYP27B1 and are growth inhibited by 25-hydroxyvitamin D-3, the major circulating form of vitamin D-3 J Nutr 136 4 2006 887 892
73. R.J. Skowronski, D.M. Peehl, and D. Feldman Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3 Endocrinology 136 1 1995 20 26
74. W.R. Wecksler, W.H. Okamura, and A.W. Norman Studies on the mode of action of vitamin D-XIV. Quantitative assessment of the structural requirements for the interaction of 1alpha, 25-dihydroxyvitamin D3 with its chick intestinal mucosa receptor system J Steroid Biochem 9 10 1978 929 937
75. M.V. Young, G.G. Schwartz, L. Wang, D.P. Jamieson, L.W. Whitlatch, and J.N. Flanagan The prostate 25-hydroxyvitamin D-1{alpha}-hydroxylase is not influenced by parathyroid hormone and calcium: implications for prostate cancer chemoprevention by vitamin D Carcinogenesis 25 2004 967 971
76. S. Swami, A.V. Krishnan, J.Y. Wang, K. Jensen, R. Horst, and M.A. Albertelli Dietary vitamin D3 and 1,25-dihydroxyvitamin D3 (Calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer Endocrinology 153 2012 2576 2587
77. K.W. Colston, and D. Vitamin And breast cancer risk Best Pract Res Clin Endocrinol Metab 22 4 2008 587 599
78. K.D. Crew, E. Shane, S. Cremers, D.J. McMahon, D. Irani, and D.L. Hershman High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy J Clin Oncol 27 13 2009 2151 2156
79. H.J. Kim, Y.M. Lee, B.S. Ko, J.W. Lee, J.H. Yu, and B.H. Son Vitamin D deficiency is correlated with poor outcomes in patients with luminal-type breast cancer Ann Surg Oncol 18 7 2011 1830 1836